Article
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology.
Lung cancer (Amsterdam, Netherlands) - 1 Oct 2024
Marks Jennifer A, Gandhi Nishant, Halmos Balazs, Marmarelis Melina E, Yeon Kim So, Bazhenova Lyudmila, Ramalingam Suresh S, Xiu Joanne, Walker Phillip, Oberley Matthew J, Ma Patrick C, Liu Stephen V
Abstract excerpt
OBJECTIVES: MET exon 14 skipping alterations (METex14+) represent a heterogeneous subgroup of non-small cell lung cancer (NSCLC) with distinct biological and genomic features. We characterized this heterogeneity in a large cohort, integrating genomic and transcriptomic profiling with clinical outcomes, to elucidate the histologic and molecular traits and survival patterns of METex14+ NSCLC. MATERIALS AND METHODS:...
Topics
Join the communities discussing this publication.
